Impact of CYP3A5 genotype on tacrolimus management in adult heart transplant recipients

被引：0
作者：
Pasternak, Amy [1 ]
Hong, Je-Won [1 ]
Lewis, Sarah [1 ]
机构：
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI USA
来源：
PHARMACOGENETICS AND GENOMICS | 2025年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
[21]   Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients [J].
Liu, Michelle ;
Hernandez, Savine ;
Aquilante, Christina L. ;
Deininger, Kimberly M. ;
Lindenfeld, Joann ;
Schlendorf, Kelly H. ;
Van Driest, Sara L. .
PHARMACOGENOMICS JOURNAL, 2024, 24 (02)
[22]   Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes [J].
Can Hu ;
Wen-jun Yin ;
Dai-yang Li ;
Jun-jie Ding ;
Ling-yun Zhou ;
Jiang-lin Wang ;
Rong-rong Ma ;
Kun Liu ;
Ge Zhou ;
Xiao-cong Zuo .
European Journal of Clinical Pharmacology, 2018, 74 :1437-1447
[23]   Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes [J].
Hu, Can ;
Yin, Wen-jun ;
Li, Dai-yang ;
Ding, Jun-jie ;
Zhou, Ling-yun ;
Wan, Jiang-lin ;
Ma, Rong-rong ;
Liu, Kun ;
Zhou, Ge ;
Zuo, Xiao-cong .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (11) :1437-1447
[24]   Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism [J].
de Jonge, Hylke ;
de Loor, Henriette ;
Verbeke, Krisitin ;
Vanrenterghem, Yves ;
Kuypers, Dirk R. J. .
PHARMACOGENOMICS, 2013, 14 (12) :1467-1480
[25]   ASSOCIATION BETWEEN TACROLIMUS AND CYP3A5 GENOTYPE IN PEDIATRIC KIDNEY TRANSPLANT [J].
Alghamdi, A. ;
Lazear, D. ;
Varnell, C. ;
Seay, S. ;
Hooper, D. ;
Darland, L. ;
Mizuno, T. ;
Ramsey, L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 :S10-S10
[26]   AN EFFECT OF DONOR-RECIPIENT CYP3A5 GENOTYPE COMBINATION ON TACROLIMUS EXPOSURE IN RENAL TRANSPLANT RECIPIENTS [J].
Warzyszynska, Karola ;
Karpeta, Edyta ;
Kosieradzki, Maciej .
TRANSPLANT INTERNATIONAL, 2021, 34 :257-257
[27]   The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients [J].
Prytula, Agnieszka A. ;
Cransberg, Karlien ;
Bouts, Antonia H. M. ;
van Schaik, Ron H. N. ;
de Jong, Huib ;
de Wildt, Saskia N. ;
Mathot, Ron A. A. .
CLINICAL PHARMACOKINETICS, 2016, 55 (09) :1129-1143
[28]   CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients [J].
Li, Yi ;
Yan, Lin ;
Shi, Yunying ;
Bai, Yangjuan ;
Tang, Jiangtao ;
Wang, Lanlan .
SPRINGERPLUS, 2015, 4
[29]   A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients [J].
Barry, Arden ;
Levine, Marc .
THERAPEUTIC DRUG MONITORING, 2010, 32 (06) :708-714
[30]   COMPARISON OF TACROLIMUS STARTING DOSES BASED ON CYP3A5 PHENOTYPE OR GENOTYPE IN KIDNEY TRANSPLANT RECIPIENTS. [J].
Largeau, B. ;
Noble, J. ;
Longuet, H. ;
Halimi, J. ;
Buchler, M. ;
Gatault, P. ;
Marquet, P. ;
Barin-Le Guellec, C. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 :S102-S103
12345